Egypt to produce 40m doses of Russia’s Sputnik V yearly

Egyptian pharmaceutical firm Minapharm has agreed to produce more than 40 million doses a year of Russia’s Sputnik V coronavirus vaccine.

Read Also:Egypt set to purchase 20m doses of Sinopharm vaccine

The Russian Direct Investment Fund (RDIF), which markets the vaccine abroad, said on Thursday.

In a statement with Minaphram,t parties agreed to begin technology transfer immediately, and the rollout is expected in the third quarter of this year.

The Production will take place in Minapharm’s biotech facility in Cairo for global distribution,” the statement said.

MTO/Reuters